Recent research is revealing key insights about the therapeutic potential of clostridial collagenase. Join us for this upcoming webinar to learn about new data on SANTYL® ointment’s unique mechanisms ...
YAVNE, Israel, Feb. 12, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair today announced the results of head-to-head ...
Healthpoint announced that the US Food and Drug Administration has granted approval to manufacture commercial supplies of Collagenase Santyl ointment, a biologic enzymatic debriding agent, at DPT ...
This episode features Dr. Jaideep Banerjee, Director of Global Clinical & Medical Affairs at Smith+Nephew, discussing the challenges of chronic wound care, the importance of standardized ...
Shares of MediWound (NASDAQ:MDWD) climbed 9% Monday after the Israeli company reported positive Phase 2 data for its chronic wound treatment EscharEx. The study was a head-to-head comparison of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback